Description
Triptorelin is a gonadrotropin releasing hormone analogue that has been used in a clinical setting to treat advanced prostate cancer as part of a multi-faceted approach to androgen deprivation therapy. Similar to luteinizing hormone releasing hormone, triptorelin is a potent inhibitor of testosterone and estrogen synthesis when given in long-term, continuous dosing.
DISCLAIMER
Products are furnished for LABORATORY RESEARCH USE ONLY. This product should only be handled by qualified, and licensed professionals. The product may not be used as a drug, agricultural or pesticide product, food additive or household chemical – and may not be misbranded as such. All information on this website is available for educational purposes only. Bodily introduction of any kind into humans and/or animals is strictly forbidden by law.